InvestorsHub Logo
Followers 2
Posts 932
Boards Moderated 0
Alias Born 12/12/2009

Re: None

Monday, 05/20/2013 2:55:15 AM

Monday, May 20, 2013 2:55:15 AM

Post# of 425918
VASCEPA has now officially eclipsed the uptake rate of Lovaza.

Sweet Jesus, this could possibly be the best long term investment of a lifetime.

BTW - an inferior drug currently on the market and named Lovaza raked in 1.3B just last year.

Vescepa is 3x better than that therapy, so....

3 x 1.3B/yr = uckfay, I wish I could count that high

Best of Wealth
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News